Publication
10/15/2005
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, Albelda SM
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Publication
5/01/1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM, Kaiser LR
Human Gene Therapy
Publication
12/01/1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.
Kucharczuk JC, Raper S, Elshami AA, Amin KM, Sterman DH, Wheeldon EB, Wilson JM, Litzky LA, Kaiser LR, Albelda SM
Human Gene Therapy
Publication
7/01/1995
Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.
Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM
Human Gene Therapy
